Plasma fibrinogen and coronary heart disease in elderly Japanese-American men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 2, 1996, Pages 262-268

  Sharp, Dan S ^a   Abbott, Robert D ^b,c,e   Burchfiel, Cecil M ^a   Rodriguez, Beatriz L ^b,c   Tracy, Russell P ^d   Yano, Katsuhiko ^b   Curb, J David ^b,c  

^a Natl Heart Lung/Blood Institute   (United States)

^b KUAKINI MEDICAL CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

coronary heart disease; erythrocyte indices; fibrinogen; non insulin dependent diabetes mellitus; smoking

Indexed keywords

FIBRINOGEN;

AGED; ARTICLE; ASIAN AMERICAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY RISK; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT;

EID: 0030063427     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.2.262     Document Type: Article

References (38)

1. Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980;1:1050-1054.
2. Ernst E. Fibrinogen as a cardiovascular risk factor: interrelationship with infections and inflammation. Eur Heart J. 1993;14:82-87.
3. Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
4. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischæmic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
5. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease studies. Circulation. 1991;83:836-844.
6. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. JAMA. 1987;258:1183-1186.
7. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
8. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med. 1992;326:242-250.
9. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Engl J Med. 1992;326:310-318.
10. Iso H, Folsom AR, Sato S, Wu KK, Shimamoto T, Koike K, Iida M, Komachi Y. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb. 1993;13:783-790.
11. Tracy RP, Bovill EG, Fried LP, Geiss G, Lee MH, Polak JF, Psaty BM, Savage PJ. The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years: results from the Cardiovascular Health Study. Ann Epidemiol. 1992;2:509-519.
12. Meade T. The epidemiology of haemostatic and other variables in coronary artery disease. In: Vestraete M, Vermylen J, Lijnen H, Arnout J, eds. Thrombosis and Haemostasis. Leuven, Belgium: International Society of Thrombosis and Haemostasis and Leuven University Press; 1987:37-59.
13. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am J Epidemiol. 1984;119:653-666.
14. Worth RM, Kagan A. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J Chron Dis. 1970;23:389-397.
15. Clauss A. Gerinnungs physiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237-246.
16. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
17. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264-270.
18. Rhoads GG, Kagan A, Yano K. Usefulness of community surveillance for the ascertainment of coronary heart disease and stroke. Int J Epidemiol. 1975;4:265-270.
19. Lane PW, Nelder JA. Analysis of covariance and standardization of instances of prediction. Biometrics. 1982;38:613-621.
20. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
21. Mittlemark MB, Psaty BM, Rautaharju PM, Fried LP, Borhani NO, Tracy RP, Gardin JM, O'Leary DH. Prevalence of cardiovascular diseases among older adults: the Cardiovascular Health Study. Am J Epidemiol. 1993;137:311-317.
22. Yarnell JWG, Sweetnam PM, Rogers S, Elwood PC, Bainton D, Baker IA, Eastham R, O'Brien JR, Etherington MD. Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative surveys. J Clin Pathol. 1987;40:909-913.
23. Rosengren A, Wilhelmsen L, Welin L, Tsipogianni A, Teger-Nilsson A, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. Br Med J. 1990;300:634-638.
24. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J Clin Epidemiol. 1990;43:913-919.
25. Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol. 1992;2:481-494.
26. Krobot K, Hense HW, Cremer P, Eberle E, Keil U. Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex: results from the second MONICA Augsburg Survey, 1989-1990. Arterioscler Thromb. 1992;12:780-788.
27. Ernst E. Fibrinogen: the plot thickens. J Clin Epidemiol. 1992;42:561-562.
28. Ernst E, Resch KL, Krauth U, Paulsen HF. Does blood rheology revert to normal after myocardial infarction? Br Heart J. 1990;64:248-250.
29. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979;1:153-156.
30. Yarnell JWG, Sweetnam PM, Elwood PC, Eastham R, Gilmour RA, O'Brien JR, Etherington MD. Haemostatic factors and ischaemic heart disease: the Caerphilly study. Br Heart J. 1985;53:483-487.
31. Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arterioscler Thromb. 1994;14:686-693.
32. Folsom AR, Qamhieg HT, Flack JM, Hilner JE, Liu K, Howard BV, Tracy RP. Plasma fibrinogen: levels and correlates in young adults. Am J Epidemiol. 1993;138:1023-1036.
33. Erslev AJ. Anemia of chronic disease. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York, NY: McGraw-Hill; 1995:518-524.
34. Kannel WB, D'Agostino RB, Belanger AJ. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol. 1992;2:457-466.
35. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation. 1993;88:837-845.
36. Krusius T, Hirvonen J, Vahtera E, Kala Risto. Short-term aspirin treatment does not reduce plasma fibrinogen concentration in young healthy adults. Thromb Res. 1994;75:653-656.
37. Hampton KK, Cerletti C, Loizou LA, Bucchi F, Donati MB, Davies JA, de Gaetano G, Prentice CRM. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo. Thromb Haemost. 1990;64:17-20.
38. Ernst E. Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology. 1994;2:87-93.